EX-FILING FEES 3 clg026_ex107.htm EX-FILING FEES

Calculation of Filing Fee Tables

 

S-1
(Form Type)

 

Inspire Veterinary Partners, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security Type   Security
Class
Title
  Fee
Calculation
or Carry
Forward Rule
  Amount
Registered(3)
  Proposed
Maximum
Offering Price
Per Unit(1)
  Maximum
Aggregate
Offering Price(2)
  Fee Rate   Amount of
Registration Fee
  Carry
Forward
Form Type
  Carry
Forward
File Number
  Carry
Forward
Initial
effective date
  Filing Fee
Previously Paid
In Connection
with Unsold
Securities
to be Carried
Forward
 
Newly Registered Securities
Fees to Be Paid   Equity   Class A Common Stock   457(o)     6,615,266     5.00    $ 33,076,330    

 

.0001102

  $                            
Fees Previously Paid                                       $                            
Carry Forward Securities
Carry Forward Securities                                                                    
    Total Offering Amounts   $ 33,076,330         $ 3,645.02                          
    Total Fees Previously Paid               $ 3,566.58                          
    Total Fee Offsets                                          
    Net Fee Due     $711,755          $ 78.44                          

 

(1) There is no current market for the securities or price at which the shares are being offered. Estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

 

(2) Pursuant to Rule 416 under the Securities Act, there is also being registered hereby such indeterminate number of additional shares of Class A Common Stock of the Registrant as may be issued or issuable because of stock splits, stock dividends, stock distributions, and similar transactions.

 

(3) Includes (i) 1,600,000 shares of Class A Common Stock offered by the issuer; (ii) 240,000 shares of Class A Common Stock that may be purchased by the underwriter pursuant to its over-allotment option to purchase additional shares; (iii) 925,001 issued and outstanding shares of Class A common stock offered by selling shareholders; (iv) 663,688 shares of Class A Common Stock that are potentially issuable upon the exercise of outstanding warrants, offered by selling shareholders; (v) 1,273,152 shares of Class A Common Stock that are potentially issuable upon the conversion of existing convertible subordinated debentures of the Company, offered by selling shareholders; (vi) 408,500 shares of Class A Common Stock that are potentially issuable upon conversion of 408,500 issued and outstanding shares of Class B Common Stock, offered by selling shareholders; and (vii) 1,504,925 shares of Class A Common Stock that are potentially issuable upon conversion of 442,458 shares of issued and outstanding Series A Preferred Stock, offered by selling shareholders.